Merck And Co Inc Income Statement Annual
MRK
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Annual GAAP In millions $) |
(FY 2003) (Dec. 30, 2003) |
(FY 2002) (Dec. 30, 2002) |
(FY 2001) (Dec. 30, 2001) |
(FY 2000) (Dec. 30, 2000) |
|
Sales Revenue, Goods, Net |
22,485.90 |
21,445.80 |
21,199.00 |
40,363.20 |
- |
Total Revenue |
22,485.90 |
21,445.80 |
21,199.00 |
40,363.20 |
0.00 |
Cost of Goods and Services Sold |
4,315.30 |
3,907.10 |
3,624.80 |
22,443.50 |
- |
Gross
Profit |
18,170.60 |
17,538.70 |
17,574.20 |
17,919.70 |
0.00 |
Selling, Administration, Marketing |
6,394.90 |
5,652.20 |
5,700.60 |
6,167.70 |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
3,279.90 |
2,677.20 |
2,456.40 |
2,343.80 |
- |
Restructuring Charges |
- |
- |
- |
- |
- |
Other exp. /-income |
- |
- |
- |
- |
- |
Special Items |
- |
- |
- |
- |
- |
Total operating costs including COS |
13,990.10 |
12,236.50 |
11,781.80 |
30,955.00 |
- |
Operating income/-loss
|
8,495.80 |
9,209.30 |
9,417.20 |
9,408.20 |
- |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss (Income) from Equity Method Investments |
- |
- |
- |
- |
- |
Equity in income of affiliates |
-474.20 |
-644.70 |
-685.90 |
-764.90 |
- |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
-81.60 |
202.30 |
155.00 |
349.00 |
- |
Total costs & expenses |
13,434.30 |
11,794.10 |
11,250.90 |
30,539.10 |
0.00 |
Income /-loss before income taxes |
9,051.60 |
9,651.70 |
9,948.10 |
9,824.10 |
0.00 |
Income taxes expenses/-benefit |
2,462.00 |
2,856.90 |
2,894.90 |
3,002.40 |
- |
Income after income taxes |
6,589.60 |
6,794.80 |
7,053.20 |
6,821.70 |
0.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
6,589.60 |
6,794.80 |
7,053.20 |
6,821.70 |
0.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
241.30 |
354.70 |
228.60 |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
6,830.90 |
7,149.50 |
7,281.80 |
6,821.70 |
0.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
6,830.90 |
7,149.50 |
7,281.80 |
6,821.70 |
0.00 |
EBIT |
9,051.60 |
9,651.70 |
9,948.10 |
9,824.10 |
0.00 |
EBITD |
10,365.80 |
11,140.00 |
11,402.30 |
11,092.50 |
0.00 |
EBITDA |
10,365.80 |
11,140.00 |
11,402.30 |
11,092.50 |
0.00 |
Per
Share (GAAP Annual, in $) |
(FY 2003) (Dec. 30, 2003) |
(FY 2002) (Dec. 30, 2002) |
(FY 2001) (Dec. 30, 2001) |
(FY 2000) (Dec. 30, 2000) |
|
Basic EPS (excl. extra
items) |
2.95 |
3.01 |
3.08 |
2.96 |
0.00 |
Extraordinary items |
0.10 |
0.16 |
0.10 |
0.00 |
0.00 |
Basic Net EPS |
3.05 |
3.17 |
3.18 |
2.96 |
0.00 |
Basic shares outstanding (Mill.
of Units) |
2,236.70 |
2,257.50 |
2,288.30 |
2,306.90 |
0.00 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
3.03 |
3.14 |
3.14 |
2.90 |
0.00 |
Diluted average shares (Mill.
of Units) |
2,253.10 |
2,277.00 |
2,322.30 |
2,353.20 |
0.00 |
Dividend per share |
1.44 |
1.4 |
1.35 |
1.19 |
- |
|
|